ID   ALKH_ECOLI              Reviewed;         213 AA.
AC   P0A955; P10177;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 1.
DT   15-MAR-2017, entry version 99.
DE   RecName: Full=KHG/KDPG aldolase;
DE   Includes:
DE     RecName: Full=4-hydroxy-2-oxoglutarate aldolase;
DE              EC=4.1.3.16;
DE     AltName: Full=2-keto-4-hydroxyglutarate aldolase;
DE              Short=KHG-aldolase;
DE   Includes:
DE     RecName: Full=2-dehydro-3-deoxy-phosphogluconate aldolase;
DE              EC=4.1.2.14;
DE     AltName: Full=2-keto-3-deoxy-6-phosphogluconate aldolase;
DE              Short=KDPG-aldolase;
DE     AltName: Full=Phospho-2-dehydro-3-deoxygluconate aldolase;
DE     AltName: Full=Phospho-2-keto-3-deoxygluconate aldolase;
GN   Name=eda; Synonyms=hga, kdgA; OrderedLocusNames=b1850, JW1839;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   PROTEIN SEQUENCE, AND ACTIVE SITE.
RC   STRAIN=K12;
RX   PubMed=3136164;
RA   Vlahos C.J., Dekker E.E.;
RT   "The complete amino acid sequence and identification of the active-
RT   site arginine peptide of Escherichia coli 2-keto-4-hydroxyglutarate
RT   aldolase.";
RL   J. Biol. Chem. 263:11683-11691(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION AS A KHG-ALDOLASE, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=1339418; DOI=10.1128/jb.174.1.102-107.1992;
RA   Patil R.V., Dekker E.E.;
RT   "Cloning, nucleotide sequence, overexpression, and inactivation of the
RT   Escherichia coli 2-keto-4-hydroxyglutarate aldolase gene.";
RL   J. Bacteriol. 174:102-107(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1624451; DOI=10.1128/jb.174.14.4638-4646.1992;
RA   Egan S.E., Fliege R., Tong S., Shibata A., Wolf R.E. Jr., Conway T.;
RT   "Molecular characterization of the Entner-Doudoroff pathway in
RT   Escherichia coli: sequence analysis and localization of promoters for
RT   the edd-eda operon.";
RL   J. Bacteriol. 174:4638-4646(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Smith J.M., Nygaard P.;
RT   "Purine and one-carbon metabolism in Escherichia coli K12: DNA
RT   sequence of a second GAR transformylase.";
RL   Submitted (JUL-1993) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=8344525; DOI=10.1016/0378-1119(93)90362-7;
RA   Carter A.T., Pearson B.M., Dickinson J.R., Lancashire W.E.;
RT   "Sequence of the Escherichia coli K-12 edd and eda genes of the
RT   Entner-Doudoroff pathway.";
RL   Gene 130:155-156(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097040; DOI=10.1093/dnares/3.6.379;
RA   Itoh T., Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K.,
RA   Kasai H., Kimura S., Kitakawa M., Kitagawa M., Makino K., Miki T.,
RA   Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S., Nakamura Y.,
RA   Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G., Seki Y.,
RA   Sivasundaram S., Tagami H., Takeda J., Takemoto K., Wada C.,
RA   Yamamoto Y., Horiuchi T.;
RT   "A 460-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 40.1-50.0 min region on the linkage map.";
RL   DNA Res. 3:379-392(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [9]
RP   ACTIVE SITE.
RX   PubMed=1978721;
RA   Vlahos C.J., Dekker E.E.;
RT   "Active-site residues of 2-keto-4-hydroxyglutarate aldolase from
RT   Escherichia coli. Bromopyruvate inactivation and labeling of glutamate
RT   45.";
RL   J. Biol. Chem. 265:20384-20389(1990).
RN   [10]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [11]
RP   FUNCTION AS A KDPG-ALDOLASE, CATALYTIC ACTIVITY, MUTAGENESIS OF GLU-45
RP   AND THR-161, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY, AND
RP   INDUCTION.
RX   PubMed=17981470; DOI=10.1016/j.bmc.2007.10.043;
RA   Walters M.J., Srikannathasan V., McEwan A.R., Naismith J.H.,
RA   Fierke C.A., Toone E.J.;
RT   "Characterization and crystal structure of Escherichia coli KDPGal
RT   aldolase.";
RL   Bioorg. Med. Chem. 16:710-720(2008).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH SUSBTRATE,
RP   REACTION MECHANISM, AND SUBUNIT.
RX   PubMed=11274385; DOI=10.1073/pnas.071380898;
RA   Allard J., Grochulski P., Sygusch J.;
RT   "Covalent intermediate trapped in 2-keto-3-deoxy-6-phosphogluconate
RT   (KDPG) aldolase structure at 1.95-A resolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3679-3684(2001).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF WILD-TYPE AND DOUBLE MUTANT
RP   IN COMPLEX WITH SUSBTRATE, MUTAGENESIS OF LYS-133; THR-161 AND
RP   ASN-168, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=11342129; DOI=10.1016/S0969-2126(00)00555-4;
RA   Wymer N., Buchanan L.V., Henderson D., Mehta N., Botting C.H.,
RA   Pocivavsek L., Fierke C.A., Toone E.J., Naismith J.H.;
RT   "Directed evolution of a new catalytic site in 2-keto-3-deoxy-6-
RT   phosphogluconate aldolase from Escherichia coli.";
RL   Structure 9:1-9(2001).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF WILD-TYPE AND MUTANT IN
RP   COMPLEX WITH SUBSTRATE, MUTAGENESIS OF GLU-45, REACTION MECHANISM, AND
RP   SUBUNIT.
RX   PubMed=16403639; DOI=10.1016/j.bmc.2005.12.022;
RA   Fullerton S.W., Griffiths J.S., Merkel A.B., Cheriyan M., Wymer N.J.,
RA   Hutchins M.J., Fierke C.A., Toone E.J., Naismith J.H.;
RT   "Mechanism of the Class I KDPG aldolase.";
RL   Bioorg. Med. Chem. 14:3002-3010(2006).
CC   -!- FUNCTION: Involved in the degradation of glucose via the Entner-
CC       Doudoroff pathway. Catalyzes the reversible, stereospecific retro-
CC       aldol cleavage of 2-Keto-3-deoxy-6-phosphogluconate (KDPG) to
CC       pyruvate and D-glyceraldehyde-3-phosphate. In the synthetic
CC       direction, it catalyzes the addition of pyruvate to electrophilic
CC       aldehydes with si-facial selectivity. It accepts some nucleophiles
CC       other than pyruvate, including 2-oxobutanoate, phenylpyruvate, and
CC       fluorobutanoate. It has a preference for the S-configuration at C2
CC       of the electrophile. {ECO:0000269|PubMed:1339418,
CC       ECO:0000269|PubMed:17981470}.
CC   -!- CATALYTIC ACTIVITY: 4-hydroxy-2-oxoglutarate = pyruvate +
CC       glyoxylate. {ECO:0000269|PubMed:17981470}.
CC   -!- CATALYTIC ACTIVITY: 2-dehydro-3-deoxy-6-phosphate-D-gluconate =
CC       pyruvate + D-glyceraldehyde 3-phosphate.
CC       {ECO:0000269|PubMed:17981470}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.1 mM for KDPG {ECO:0000269|PubMed:11342129,
CC         ECO:0000269|PubMed:17981470};
CC         KM=9 mM for 2-oxobutyrate {ECO:0000269|PubMed:11342129,
CC         ECO:0000269|PubMed:17981470};
CC         KM=10 mM for pyruvate {ECO:0000269|PubMed:11342129,
CC         ECO:0000269|PubMed:17981470};
CC         Note=Kcat is 80 sec(-1) for KDPG, 0.012 sec(-1) for pyruvate and
CC         0.0004 sec(-1) for 2-oxobutyrate.;
CC   -!- PATHWAY: Carbohydrate acid metabolism; 2-dehydro-3-deoxy-D-
CC       gluconate degradation; D-glyceraldehyde 3-phosphate and pyruvate
CC       from 2-dehydro-3-deoxy-D-gluconate: step 2/2.
CC   -!- PATHWAY: Carbohydrate metabolism; glyoxylate and dicarboxylate
CC       metabolism.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:11274385,
CC       ECO:0000269|PubMed:11342129, ECO:0000269|PubMed:16403639}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-558114, EBI-558114;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- INDUCTION: Constitutive, three-fold induction occurs for growth on
CC       gluconate and two-fold for growth on hexuronic acids.
CC       {ECO:0000269|PubMed:17981470}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene lose KHG aldolase
CC       activity. {ECO:0000269|PubMed:1339418}.
CC   -!- SIMILARITY: Belongs to the KHG/KDPG aldolase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X68871; CAA48732.1; -; Genomic_DNA.
DR   EMBL; M87458; AAA23723.1; -; Genomic_DNA.
DR   EMBL; L20897; AAA23862.1; -; Genomic_DNA.
DR   EMBL; X63694; CAA45222.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74920.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15658.1; -; Genomic_DNA.
DR   PIR; B42986; ADECOG.
DR   RefSeq; NP_416364.1; NC_000913.3.
DR   RefSeq; WP_000800512.1; NZ_LN832404.1.
DR   PDB; 1EUA; X-ray; 1.95 A; A/B/C=1-213.
DR   PDB; 1EUN; X-ray; 2.00 A; A/B/C=1-213.
DR   PDB; 1FQ0; X-ray; 2.10 A; A/B/C=1-213.
DR   PDB; 1FWR; X-ray; 2.70 A; A/B/C=1-213.
DR   PDB; 1WAU; X-ray; 2.80 A; A=1-213.
DR   PDB; 1WBH; X-ray; 1.55 A; A/B/C=1-213.
DR   PDB; 2C0A; X-ray; 1.55 A; A/B/C=1-213.
DR   PDBsum; 1EUA; -.
DR   PDBsum; 1EUN; -.
DR   PDBsum; 1FQ0; -.
DR   PDBsum; 1FWR; -.
DR   PDBsum; 1WAU; -.
DR   PDBsum; 1WBH; -.
DR   PDBsum; 2C0A; -.
DR   ProteinModelPortal; P0A955; -.
DR   SMR; P0A955; -.
DR   BioGrid; 4259153; 13.
DR   DIP; DIP-36196N; -.
DR   IntAct; P0A955; 9.
DR   STRING; 511145.b1850; -.
DR   DrugBank; DB04272; Citric Acid.
DR   SWISS-2DPAGE; P0A955; -.
DR   EPD; P0A955; -.
DR   PaxDb; P0A955; -.
DR   PRIDE; P0A955; -.
DR   EnsemblBacteria; AAC74920; AAC74920; b1850.
DR   EnsemblBacteria; BAA15658; BAA15658; BAA15658.
DR   GeneID; 946367; -.
DR   KEGG; ecj:JW1839; -.
DR   KEGG; eco:b1850; -.
DR   PATRIC; 32119021; VBIEscCol129921_1928.
DR   EchoBASE; EB0252; -.
DR   EcoGene; EG10256; eda.
DR   eggNOG; ENOG4108UHU; Bacteria.
DR   eggNOG; COG0800; LUCA.
DR   HOGENOM; HOG000233114; -.
DR   InParanoid; P0A955; -.
DR   KO; K01625; -.
DR   OMA; FLISPGL; -.
DR   PhylomeDB; P0A955; -.
DR   BioCyc; EcoCyc:KDPGALDOL-4OH2OXOGLUTARALDOL-MONOMER; -.
DR   BioCyc; MetaCyc:KDPGALDOL-4OH2OXOGLUTARALDOL-MONOMER; -.
DR   BRENDA; 4.1.2.14; 2026.
DR   BRENDA; 4.1.3.42; 2026.
DR   UniPathway; UPA00227; -.
DR   UniPathway; UPA00856; UER00829.
DR   EvolutionaryTrace; P0A955; -.
DR   PRO; PR:P0A955; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008675; F:2-dehydro-3-deoxy-phosphogluconate aldolase activity; IMP:EcoliWiki.
DR   GO; GO:0008700; F:4-hydroxy-2-oxoglutarate aldolase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008152; P:metabolic process; IEA:UniProtKB-KW.
DR   CDD; cd00452; KDPG_aldolase; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR000887; Aldlse_KDPG_KHG.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR031337; KDPG/KHG_AS_1.
DR   InterPro; IPR031338; KDPG/KHG_AS_2.
DR   Pfam; PF01081; Aldolase; 1.
DR   TIGRFAMs; TIGR01182; eda; 1.
DR   PROSITE; PS00159; ALDOLASE_KDPG_KHG_1; 1.
DR   PROSITE; PS00160; ALDOLASE_KDPG_KHG_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Lyase; Multifunctional enzyme; Reference proteome; Schiff base.
FT   CHAIN         1    213       KHG/KDPG aldolase.
FT                                /FTId=PRO_0000201037.
FT   REGION        8      9       Substrate binding.
FT   ACT_SITE     45     45       Proton acceptor.
FT   ACT_SITE     49     49
FT   ACT_SITE    133    133       Schiff-base intermediate with substrate.
FT   BINDING      49     49       Substrate. {ECO:0000269|PubMed:16403639}.
FT   BINDING      73     73       Substrate. {ECO:0000269|PubMed:16403639}.
FT   BINDING     133    133       Substrate (covalent).
FT                                {ECO:0000269|PubMed:16403639}.
FT   BINDING     161    161       Substrate. {ECO:0000269|PubMed:16403639}.
FT   BINDING     163    163       Substrate; via amide nitrogen.
FT                                {ECO:0000269|PubMed:16403639}.
FT   BINDING     184    184       Substrate. {ECO:0000269|PubMed:16403639}.
FT   SITE        161    161       Plays a major role in determining the
FT                                stereoselectivity.
FT   MUTAGEN      45     45       E->N: 50-fold decrease in catalytic
FT                                efficiency and 6-fold decrease of binding
FT                                affinity. {ECO:0000269|PubMed:16403639,
FT                                ECO:0000269|PubMed:17981470}.
FT   MUTAGEN     133    133       K->Q: Absence of aldolase activity. Shows
FT                                a markedly altered substrate specificity
FT                                relative to the wild-type, with an
FT                                enhanced activity against pyridine
FT                                carboxaldehyde, benzaldehyde, and alpha-
FT                                ketobutyrate; when associated with k-161.
FT                                {ECO:0000269|PubMed:11342129}.
FT   MUTAGEN     161    161       T->K: Shows activity significantly
FT                                greater than wild-type. Shows a markedly
FT                                altered substrate specificity relative to
FT                                the wild-type, with an enhanced activity
FT                                against pyridine carboxaldehyde,
FT                                benzaldehyde, and alpha-ketobutyrate;
FT                                when associated with Q-133.
FT                                {ECO:0000269|PubMed:11342129,
FT                                ECO:0000269|PubMed:17981470}.
FT   MUTAGEN     161    161       T->V: Little stereoselectivity, accepting
FT                                KDPG and KDPGal as substrate with roughly
FT                                equal efficacy. It strongly diminishes
FT                                the activity against KDPG and slightly
FT                                increases activity against KDPGal.
FT                                {ECO:0000269|PubMed:11342129,
FT                                ECO:0000269|PubMed:17981470}.
FT   MUTAGEN     168    168       N->S: Shows activity significantly
FT                                greater than wild-type.
FT                                {ECO:0000269|PubMed:11342129}.
FT   HELIX         8     13       {ECO:0000244|PDB:1WBH}.
FT   STRAND       16     21       {ECO:0000244|PDB:1WBH}.
FT   HELIX        26     28       {ECO:0000244|PDB:1WBH}.
FT   HELIX        29     38       {ECO:0000244|PDB:1WBH}.
FT   STRAND       43     48       {ECO:0000244|PDB:1WBH}.
FT   HELIX        53     63       {ECO:0000244|PDB:1WBH}.
FT   STRAND       67     73       {ECO:0000244|PDB:1WBH}.
FT   HELIX        77     86       {ECO:0000244|PDB:1WBH}.
FT   STRAND       91     95       {ECO:0000244|PDB:1WBH}.
FT   HELIX        98    106       {ECO:0000244|PDB:1WBH}.
FT   STRAND      107    109       {ECO:0000244|PDB:1WBH}.
FT   STRAND      111    117       {ECO:0000244|PDB:1WBH}.
FT   HELIX       118    126       {ECO:0000244|PDB:1WBH}.
FT   STRAND      131    134       {ECO:0000244|PDB:1WBH}.
FT   TURN        135    141       {ECO:0000244|PDB:1WBH}.
FT   HELIX       142    150       {ECO:0000244|PDB:1WBH}.
FT   STRAND      157    163       {ECO:0000244|PDB:1WBH}.
FT   TURN        166    168       {ECO:0000244|PDB:1WBH}.
FT   HELIX       169    173       {ECO:0000244|PDB:1WBH}.
FT   STRAND      181    183       {ECO:0000244|PDB:1WBH}.
FT   HELIX       184    186       {ECO:0000244|PDB:1WBH}.
FT   HELIX       189    194       {ECO:0000244|PDB:1WBH}.
FT   HELIX       197    210       {ECO:0000244|PDB:1WBH}.
SQ   SEQUENCE   213 AA;  22284 MW;  CC8D51B50480D0B7 CRC64;
     MKNWKTSAES ILTTGPVVPV IVVKKLEHAV PMAKALVAGG VRVLEVTLRT ECAVDAIRAI
     AKEVPEAIVG AGTVLNPQQL AEVTEAGAQF AISPGLTEPL LKAATEGTIP LIPGISTVSE
     LMLGMDYGLK EFKFFPAEAN GGVKALQAIA GPFSQVRFCP TGGISPANYR DYLALKSVLC
     IGGSWLVPAD ALEAGDYDRI TKLAREAVEG AKL
//
